The ileal FGF15/19 to hepatic FGFR4 axis regulates liver regeneration after partial hepatectomy in mice

被引:16
作者
Li, Qiang [1 ,2 ]
Zhao, Qiang [1 ,2 ]
Zhang, Chuanzhao [1 ,2 ]
Zhang, Peng [1 ,2 ]
Hu, Anbin [1 ,2 ]
Zhang, Longjuan [3 ]
Schroder, Paul M. [4 ]
Ma, Yi [1 ,2 ]
Guo, Zhiyong [1 ,2 ]
Zhu, Xiaofeng [1 ,2 ]
He, Xiaoshun [1 ,2 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Organ Transplant Ctr, 58 Zhongshan Er Rd, Guangzhou 510080, Guangdong, Peoples R China
[2] Guangdong Prov Key Lab Construct Project Organ Do, Guangzhou 510080, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 1, Lab Surg, Guangzhou 510080, Guangdong, Peoples R China
[4] Univ Toledo, Coll Med, Toledo, OH 43614 USA
基金
国家高技术研究发展计划(863计划); 中国国家自然科学基金;
关键词
FGF15; FGF19; FGFR4; Liver regeneration; Hepatectomy; GROWTH-FACTOR; 15; BILE-ACID; GENE-EXPRESSION; FATTY LIVER; HEPATOCELLULAR-CARCINOMA; CANCER; RECEPTOR; FGF19; IDENTIFICATION; ACTIVATION;
D O I
10.1007/s13105-018-0610-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fibroblast growth factor (FGF) has been considered to modulate liver regeneration (LR) after partial hepatectomy (PH) at the tissue level. Previous studies have demonstrated that FGF15 and FGF19 induce the activation of its receptor, FGF receptor 4 (FGFR4), which can promote hepatocellular carcinoma progression and regulate liver lipid metabolism. In this study, we aimed to explore the role of the ileal FGF15/19- hepatic FGFR4 axis in the LR after PH. Male C57BL/6 mice aged 8-12 weeks were partially hepatectomized and assessed for expression of ileal FGF15/19 to hepatic FGFR4 signaling. We used recombinant human FGF19 protein and a small interfering RNA (siRNA) of FGFR4 to regulate expression of the FGF15/19-FGFR4 axis in vitro and in vivo. The proliferation and cell cycle of hepatocytes, the expression levels of FGF15/19-FGFR4 downstream molecules, liver recovery, and lipid metabolism were assessed. We found that both ileal and serum FGF15 expression were upregulated and hepatic FGFR4 was activated after PH in mice. FGF15/19 promoted cell cycle progression, enhanced proliferation, and reduced hepatic lipid accumulation of hepatocytes both in vitro and in vivo. Furthermore, the proliferative effect and lipid regulatory properties of FGF15/19 were dependent on FGFR4 in hepatocytes. In addition, ileal FGF15/19-hepatic FGFR4 transduction during hepatocyte proliferation was regulated by extracellular regulated protein kinase (ERK) 1/2. In conclusion, the ileal FGF15/19 to hepatic FGFR4 axis is activated and promotes LR after PH in mice, supporting the potential of ileal FGF15/19 to hepatic FGFR4 axis-targeted therapy to enhance LR after PH.
引用
收藏
页码:247 / 260
页数:14
相关论文
共 51 条
  • [1] Impaired liver regeneration in mice by lipopolysaccharide via TNF-α/kallikrein-mediated activation of latent TGF-β
    Akita, K
    Okuno, M
    Enya, M
    Imai, S
    Moriwaki, H
    Kawada, N
    Suzuki, Y
    Kojima, S
    [J]. GASTROENTEROLOGY, 2002, 123 (01) : 352 - 364
  • [2] Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration
    Alvarez-Sola, Gloria
    Uriarte, Iker
    Ujue Latasa, M.
    Fernandez-Barrena, Maite G.
    Urtasun, Raquel
    Elizalde, Maria
    Barcena-Varela, Marina
    Jimenez, Maddalen
    Chang, Haisul C.
    Barbero, Roberto
    Catalan, Victoria
    Rodriguez, Amaia
    Fruhbeck, Gema
    Gallego-Escuredo, Jose M.
    Gavalda-Navarr, Aleix
    Villarroya, Francesc
    Rodriguez-Ortigosa, Carlos M.
    Corrales, Fernando J.
    Prieto, Jesus
    Berraondo, Pedro
    Berasain, Carmen
    Avila, Matias A.
    [J]. GUT, 2017, 66 (10) : 1818 - 1828
  • [3] The FGF family: biology, pathophysiology and therapy
    Beenken, Andrew
    Mohammadi, Moosa
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (03) : 235 - 253
  • [4] The mechanisms of action of PPARs
    Berger, J
    Moller, DE
    [J]. ANNUAL REVIEW OF MEDICINE, 2002, 53 : 409 - 435
  • [5] Regulation of fatty acid transport by fatty acid translocase/CD36
    Bonen, A
    Campbell, SE
    Benton, CR
    Chabowski, A
    Coort, SLM
    Han, XX
    Koonen, DPY
    Glatz, JFC
    Luiken, JJFP
    [J]. PROCEEDINGS OF THE NUTRITION SOCIETY, 2004, 63 (02) : 245 - 249
  • [6] Molecular Pathways: Fibroblast Growth Factor Signaling: A New Therapeutic Opportunity in Cancer
    Brooks, A. Nigel
    Kilgour, Elaine
    Smith, Paul D.
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (07) : 1855 - 1862
  • [7] Soluble FGFR4 extracellular domain inhibits FGF19-induced activation of FGFR4 signaling and prevents nonalcoholic fatty liver disease
    Chen, Qiang
    Jiang, Yuan
    An, Yuan
    Zhao, Na
    Zhao, Yang
    Yu, Chundong
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 409 (04) : 651 - 656
  • [8] Identification of a hormonal basis for gallbladder filling
    Choi, Mihwa
    Moschetta, Antonio
    Bookout, Angie L.
    Peng, Li
    Umetani, Michihisa
    Holmstrom, Sam R.
    Suino-Powell, Kelly
    Xu, H. Eric
    Richardson, James A.
    Gerard, Robert D.
    Mangelsdorf, David J.
    Kliewer, Steven A.
    [J]. NATURE MEDICINE, 2006, 12 (11) : 1253 - 1255
  • [9] Ezzat S, 2005, CLIN CANCER RES, V11, P1336
  • [10] Liver regeneration
    Fausto, N
    Campbell, JS
    Riehle, KJ
    [J]. HEPATOLOGY, 2006, 43 (02) : S45 - S53